Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis (Q69925917)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1988

edit

Language	Label	Description	Also known as
English	Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis	scientific article published on 01 December 1988

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

title

Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

main subject

sulfasalazine

1 reference

based on heuristic

inferred from title

ulcerative colitis

1 reference

based on heuristic

inferred from title

author name string

C J Mulder

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

G N Tytgat

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

I T Weterman

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

W Dekker

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

P Blok

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

M Schrijver

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

H van der Heide

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

language of work or name

English

0 references

publication date

1 December 1988

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

published in

Gastroenterology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

volume

95

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

page(s)

1449-1453

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

cites work

Sulphasalazine and salicylazosulphadimidine in ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

A complication of SASP therapy: hair loss

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Pentasa in lieu of sulfasalazine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0016-5085%2888%2980061-1

retrieved

7 January 2021

Identifiers

DOI

10.1016/S0016-5085(88)80061-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

PubMed publication ID

2903110

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2903110

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2903110%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 October 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69925917&oldid=1899586091"